CSIMarket
 
Goodrx Holdings Inc   (GDRX)
Other Ticker:  
 
 
Price: $6.9100 $0.14 2.068%
Day's High: $7.03 Week Perf: -5.99 %
Day's Low: $ 6.70 30 Day Perf: 4.38 %
Volume (M): 1,554 52 Wk High: $ 9.37
Volume (M$): $ 10,738 52 Wk Avg: $6.05
Open: $6.72 52 Wk Low: $4.14



 Market Capitalization (Millions $) 3,064
 Shares Outstanding (Millions) 443
 Employees 900
 Revenues (TTM) (Millions $) 750
 Net Income (TTM) (Millions $) -9
 Cash Flow (TTM) (Millions $) -85
 Capital Exp. (TTM) (Millions $) 56

Goodrx Holdings Inc
Goodrx Holdings Inc is a publicly traded healthcare technology company that specializes in providing price transparency and cost-saving solutions for prescription drugs. The company was founded in 2011 by Doug Hirsch, a former executive at Yahoo, and Trevor Bezdek, a former hedge fund analyst.

Goodrx operates a website and mobile application that allows consumers to search for the lowest prices on prescription drugs at nearby pharmacies. The website aggregates pricing information from numerous sources, including pharmacy chains, mail-order drug services, and Goodrx's own database of prescription drug prices. Goodrx also provides coupons and discount codes that can be used at pharmacies to save on prescription drug costs.

In addition to its consumer-facing services, Goodrx also offers a number of products and services for healthcare providers and payers. These include tools for medication adherence monitoring, drug utilization review, and formulary management. The company also offers customized solutions for employers, health plans, and pharmacies to help them reduce prescription drug costs.

Goodrx went public in 2020 and is listed on the NASDAQ under the ticker symbol GDRX. As of 2021, the company has a market capitalization of approximately $16 billion and employs over 1,000 people. Goodrx has been the recipient of several awards and honors, including recognition by Fortune as one of the "Best Workplaces in Health Care and Biopharma" in 2021.


   Company Address: 2701 Olympic Boulevard Santa Monica 90404 CA
   Company Phone Number: 268-2822   Stock Exchange / Ticker: NASDAQ GDRX
   


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Goodrx Holdings Inc

Headline: GoodRx Holdings Inc. Faces Loss Despite Revenue Growth in Q4 2023

GoodRx Holdings Inc. is a company that has been focused on making healthcare more affordable and accessible for people across the United States. Recently, their stock experienced a drop of 4.08% in February 2024, bringing the share price down by 21.99% in the past 90 days. Despite this drop, the stock is still trading on the NASDAQ at a value that is 7% above its 52-week average.
Looking at the company's financials, it is evident that GoodRx Holdings Inc. has been experiencing diminishing returns. In the fiscal period ending December 31, 2023, the company's earnings per share (EPS) expanded to $-0.06 per share, compared to $0.00 per share the previous year. Additionally, the EPS improved from $-0.09 per share from the preceding financial reporting period.

Product Service News

Redefining the Economics of American Healthcare: The Transformative Impact of GoodRx

Published Thu, Jan 11 2024 2:00 PM UTC

Ever since its inception, GoodRx, based in Santa Monica, California, has championed the cause of making healthcare more affordable and accessible across the United States. This leading destination for prescription savings has now released a report that encapsulates its transformative impact on social welfare through its mission of helping millions of Americans access afforda...

Goodrx Holdings Inc

Goodrx Holdings Inc Reports Third Quarter of 2023 with Per Share Shortfall of -$0.09, Highlighting Financial Struggles Ahead

GoodRx Holdings Inc, a leading provider of prescription drug pricing information and healthcare services, experienced a loss in the third quarter of 2023. The company reported a loss of $-0.09 per share, compared to a loss of $-0.10 per share in the same quarter the previous year. Additionally, the income per share fell from $0.14 per share in the preceding quarter.
The revenue for the third quarter contracted by -3.929% to $179.96 million, down from $187.32 million in the corresponding quarter of the previous year. Sequentially, the revenue decreased by -5.124% from $189.68 million. This decline in revenue is in contrast to the overall trend in the Cloud Computing & Data Analytics sector, which saw a 3.59% rise in revenue from the third quarter of 2022 to the third quarter of 2023.

Goodrx Holdings Inc

Goodrx Holdings Inc Reports Fiscal Q2 Results: Earnings Soar by $46.72 Million due to Income Tax Provisions

Goodrx Holdings Inc, a leading name in the Cloud Computing & Data Analytics sector, recently announced its fiscal second-quarter results for 2023. While the company experienced a modest revenue contraction, its earnings per share remained unchanged at $0.14. The revenue depreciated by -1.106% to $189.68 million compared to the previous year.
However, Goodrx Holdings Inc's performance in the second quarter of 2023 was in contrast to the rest of the sector. The overall sector recorded a revenue improvement of 1.70% relative to the corresponding period a year ago. Despite this, Goodrx Holdings Inc managed to turn its earnings per share positive from the previous quarter, which was at $-0.01 per share.

Goodrx Holdings Inc

Struggling Goodrx Holdings Inc Faces Steep Revenue Decline, Threatening its Financial Stability in First Quarter 2023

Goodrx Holdings Inc is a popular American company that provides an online platform for comparing drug prices and obtaining discounts through various healthcare plans. As a technology-based company, Goodrx is known for its innovative solutions that help its customers save money on prescription drugs. However, the company has been experiencing difficult times financially, as reflected in its recent financial statements.
Goodrx Holdings Inc recorded a cumulative net loss of $-48 million during the twelve months ending in the first quarter of 2023, resulting in a negative return on assets (ROA) of -3.04%. This is a significant setback for the company, which needs to improve its financial position to remain competitive in the marketplace. Unfortunately, the company has not performed as well as its competitors in the technology sector, with 212 other companies having a higher return on assets.






 

Goodrx Holdings Inc's Segments
 
 
• View Complete Report




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com